CTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS Health
February 24, 2021 at 08:15 AM EST
PALO ALTO, Calif., Feb. 24, 2021 /PRNewswire/ -- CTSI Oncology Solutions, a Varian (NYSE: VAR) company that provides oncology services for healthcare providers worldwide, has entered into a long-term, multi-year agreement with CHRISTUS Health, a Texas-based health system, to provide a broad spectrum of technology-enabled services in radiation oncology. Under the agreement, CTSI will provide six CHRISTUS radiation oncology departments with comprehensive support designed to increase efficiency, track and enhance quality, and reduce costs.
CTSI's Oncology-as-a-Service (OaaS) programs combines technology-enabled operations, clinical human resources, and advanced medical technology to support radiation oncology providers to deploy and optimize technology adoption while increasing quality and efficiency and decreasing operational costs.
CTSI's engagement with CHRISTUS Health will enable the six CHRISTUS radiation oncology clinics to centralize some of the very complex, high-cost activities that are essential for modern radiation oncology practices—activities that consume a lot of technical and human resources when reproduced separately at every treatment center. In addition, CTSI will provide CHRISTUS with two centralized software platforms:
1) LION, or "Large Integrated Oncology Network," enabling secure collaboration between personnel at each of the six participating CHRISTUS sites and CTSI consultants.
2) A hosted, cloud-based version of Varian's Eclipse™ treatment planning software, which will be continually upgraded as new capabilities are added—something that cannot be done when each treatment center separately hosts the software.
"Our new partnership with CHRISTUS is especially exciting because it allows us to optimize clinical operations across these multiple sites by eliminating duplication," said Andrew Shogan, Senior Vice President of CTSI. "The engagement will enable the CHRISTUS team to leverage our consultants' technical expertise and industry insights, as well as our proprietary, cloud-based OaaS platform, to deliver quality care for patients while decreasing costs."
In addition to the OaaS engagement with CTSI, CHRISTUS Health will install six new linear accelerators including TrueBeam® and Edge® radiotherapy systems.
"This partnership offers our patients access to more advanced technology and the clinical benefits from centralized management of our oncology network. This improves quality and enhances operational efficiencies by leveraging the Oncology as a Service approach to providing comprehensive solutions," said Dr. David Benner, Vice President of Clinical Ancillary Services, CHRISTUS Health. "Varian was chosen to equip our facilities with state-of-the-art technology and clinical services because they are a proven leader."
About Varian Medical Systems
About CHRISTUS Health
INVESTOR RELATIONS CONTACT: